Norway wants to lead the way in health innovation, but funding remains uncertain
Norway has major ambitions to become a leading nation in the development of the medicines of the future. Researchers, entrepreneurs, and investors point out that the country already possesses strong prerequisites, such as high expertise, good access to data, and a solid academic environment.
Despite this potential, there is uncertainty regarding how this development will be financed. Many industry players express concern that while Norway wants to be at the technological forefront, the willingness to foot the bill for innovation projects is insufficient.
To succeed in creating a competitive health industry, experts believe that closer cooperation between the state and private investors is required. Without long-term investments, Norway risks losing good ideas and talent to other countries.
The debate about the future of the healthcare system is therefore not just about science, but also about political priorities. The question is whether Norway is willing to commit the necessary resources to make the country an international player in medical innovation.